Bharat Biotech's coronavirus vaccine candidate 'Covaxin' has shown promising results. Phase I and Phase II results have shown that the vaccine was well tolerated in all groups. Bharat Biotech said Covaxin showed robust immune response with no side-effects in Phase I and Phase II human trials.
Comments